NCT02485613
- Conditions
- Amyloidosis, Metabolic Diseases, Nutritional and Metabolic Diseases, +1 more
- Locations
-
Not specified
Clinical trial condition
Amyloidosis
Explore clinical trials studying Amyloidosis. Study availability and eligibility vary by location and protocol.
95 public trials
27 recruiting studies
Amyloidosis trial results
NCT00919139
- Conditions
- Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +25 more
- Locations
-
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- Alta Bates Summit Comprehensive Cancer Center Berkeley, California, United States
- Peninsula Medical Center Burlingame, California, United States
- University of California Davis Cancer Center Sacramento, California, United States
NCT01527032
- Conditions
- Amyloidosis, Metabolic Diseases, Nutritional and Metabolic Diseases, +1 more
- Locations
-
Not specified
NCT01606280
- Conditions
- Amyloidosis, Metabolic Diseases, Nutritional and Metabolic Diseases, +1 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
NCT01998503
- Conditions
- Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +9 more
- Locations
-
- Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine Nanjing, Jiangsu, China
Completed
Open-Label Phase 1/2 Study of VELCADE for Injection in Patients With Light-chain (AL)-Amyloidosis
NCT00298766
- Conditions
- Amyloidosis, Metabolic Diseases, Nutritional and Metabolic Diseases, +1 more
- Locations
-
- Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
- Winship Cancer Center - Emory Clinic School of Medicine Atlanta, Georgia, United States
- Boston Medical Center Boston, Massachusetts, United States
- MSKCC New York, United States
NCT00607581
- Conditions
- Amyloidosis, Metabolic Diseases, Nutritional and Metabolic Diseases, +1 more
- Locations
-
- Amyloidosis Research and Treatment Center - Fondazione IRCCS Policlinico San Matteo Pavia, Italy
NCT00621400
- Conditions
- Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +9 more
- Locations
-
- CHRU d'Amiens Amiens, France
- CHRU de Lille Lille, France
- CHU de Limoges Limoges, France
- CHU de Nantes Nantes, France
Completed
Efficacy of CC-5013 (Revlimid or Lenalidomide) in Patients With Primary Systemic Amyloidosis
NCT00166413
- Conditions
- Amyloidosis, Metabolic Diseases, Nutritional and Metabolic Diseases, +1 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
NCT00186407
- Conditions
- Amyloidosis, Blood and Marrow Transplant (BMT), Metabolic Diseases, +2 more
- Locations
-
- Stanford University School of Medicine Stanford, California, United States